Anxiety symptoms and quality of life in middle-aged and older outpatients with schizophrenia and schizoaffective disorder

被引:52
作者
Wetherell, JL
Palmer, BW
Thorp, SR
Patterson, TL
Golshan, S
Jeste, DV
机构
[1] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA
[2] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA
关键词
D O I
10.4088/JCP.v64n1212
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: This study examined whether anxiety symptoms make an independent contribution to poorer quality of life among middle-aged and older outpatients with schizophrenia or schizoaffective disorder. Method. We evaluated data from an ongoing study of 163 older patients with DSM-III-R or DSM-IV schizophrenia or schizoaffective disorder who were enrolled in research at the University of California, San Diego, Advanced Center for Interventions and Services Research from October 1992 to April 1998. Measures used were the anxiety, somatization, obsessive-compulsive, and phobic anxiety subscales of the Brief Symptom Inventory. We performed hierarchical multiple regressions with forced entry of variables to determine whether anxiety symptoms significantly predicted poorer health-related quality of life (measured by 2 scales) after controlling for demographic variables, akathisia, cognitive impairment, depressive symptoms, and overall psychopathology. Results: Anxiety symptoms were associated with poorer outcomes on overall quality of wellbeing and subscales representing vitality, social functioning, and role functioning limitations due to physical problems. In most cases, the proportion of variance in quality of life accounted for by anxiety symptoms was greater than that accounted for by depressive symptoms. Conclusions: Results suggest that anxiety symptoms have a significant negative impact on the quality of life of middle-aged and older patients with schizophrenia and schizoaffective disorder.
引用
收藏
页码:1476 / 1482
页数:7
相关论文
共 42 条
[1]  
[Anonymous], QUALITY LIFE ASSESSM
[2]  
[Anonymous], 1990, USERS GUIDE STRUCTUR
[3]  
Arlow P B, 1997, J Psychother Pract Res, V6, P145
[4]   A RATING-SCALE FOR DRUG-INDUCED AKATHISIA [J].
BARNES, TRE .
BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 :672-676
[5]   TREATMENT OF OBSESSIVE-COMPULSIVE SYMPTOMS IN SCHIZOPHRENIC-PATIENTS WITH CLOMIPRAMINE [J].
BERMAN, I ;
SAPERS, BL ;
CHANG, HHJ ;
LOSONCZY, MF ;
SCHMILDLER, J ;
GREEN, AI .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (03) :206-210
[6]  
BOYD JH, 1986, AM J PSYCHIAT, V143, P1569
[7]   Clinical and cognitive factors associated with verbal memory task performance in patients with schizophrenia [J].
Brébion, G ;
Groman, JM ;
Malaspina, D ;
Sharif, Z ;
Amador, X .
AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (05) :758-764
[8]  
CASTLE D, 2003, PHARM PSYCHOSOCIAL T, P63
[9]   The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder [J].
Cosoff, SJ ;
Hafner, RJ .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 1998, 32 (01) :67-72
[10]  
Derogatis L.R., 1975, BRIEF SYMPTOM INVENT